Epidermal growth factor receptor - PDFSEARCH.IO - Document Search Engine

Epidermal growth factor receptor
Results: 296

#	Item
91	Clinical Cancer Research Cancer Therapy: Clinical Add to Reading List Source URL: www.cimab-sa.com Language: English - Date: 2011-03-23 11:27:25 Oncogenes Tyrosine kinase receptors Amines Quinazolines Alkynes Epidermal growth factor receptor Nimotuzumab Zalutumumab Cetuximab Medicine Chemistry Biology
92	Differential protein signatures in erlotinib-sensitive and resistant lung cancer cell lines in vitro and in vivo 1Deb 1Ying Add to Reading List Source URL: www.somalogic.com Language: English - Date: 2014-06-25 17:02:13 Proteins Erlotinib Cyclin-dependent kinase 2 Cyclin CDKN1B Epidermal growth factor receptor Tyrosine kinase Proteomics Protein kinase inhibitor Biology Cell biology Cell cycle
93	Public Summary Document Application No. 1161 – Assessment of EGFR mutation testing for the use of gefitinib in locally advanced or metastatic nonsquamous NSCLC Sponsor/Applicant/s: AstraZeneca Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:57 Amines Quinazolines Lung cancer Organofluorides Biotechnology Gefitinib Epidermal growth factor receptor Non-small-cell lung carcinoma Biomarker Chemistry Medicine Organic chemistry
94	1293 Consultation Decision Analytic Protocol (DAP) to guide the assessment of Epidermal Growth Factor Receptor (EGFR) gene mutation testing for eligibility for afatinib treatment in patients with stage IIIB or stage IV Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:25 Quinazolines Tyrosine kinase receptors Organofluorides Amines Organochlorides Gefitinib Erlotinib Epidermal growth factor receptor Afatinib Chemistry Organic chemistry Medicine
95	Stakeholder meeting statement Breast cancer treatment with anti-human epidermal growth factor receptor 2 (anti-HER2+) monoclonal antibody drugs A stakeholder meeting was held on 28 May 2014 to discuss how the treatment Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-13 00:39:15 Ribbon symbolism Cancer treatments Trastuzumab Lapatinib Breast cancer treatment Pertuzumab Breast cancer HER2/neu Management of cancer Chemistry Organic chemistry Medicine
96	Public Summary Document Application No. 1173 – Epidermal Growth Factor Receptor (EGFR) gene mutation testing for eligibility for erlotinib treatment as a first line therapy in patients with locally advanced or metastat Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:40 Amines Quinazolines Lung cancer Organofluorides Alkynes Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Medicine Organic chemistry
97	1293 Final Decision Analytic Protocol (DAP) to guide the assessment of Epidermal Growth Factor Receptor (EGFR) gene mutation testing for eligibility for afatinib treatment in patients with stage IIIB or stage IV non-sma Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:26 Quinazolines Organofluorides Amines Organochlorides Lung cancer Gefitinib Erlotinib Epidermal growth factor receptor Afatinib Chemistry Organic chemistry Medicine
98	Public Summary Document Application No. 1173 – Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for a Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:40 Quinazolines Amines Organofluorides Organochlorides Lung cancer Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Organic chemistry Medicine
99	Public Summary Document Application No. 1161 – Gefitinib first line testing for mutations of epidermal growth factor receptor (EGFR) in patients with metastatic non-small cell lung cancer (NSCLC) Sponsor/Applicant/s: Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:56 Quinazolines Amines Organofluorides Organochlorides Lung cancer Gefitinib Epidermal growth factor receptor Erlotinib Non-small-cell lung carcinoma Chemistry Organic chemistry Medicine
100	MSAC Application 1173: Consultation Decision Analytic Protocol (DAP) to guide the assessment of Epidermal Growth Factor Receptor (EGFR) testing for eligibility for erlotinib treatment as a first line therapy in patients Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:43 Lung cancer Amines Quinazolines Organofluorides Alkynes Gefitinib Erlotinib Non-small-cell lung carcinoma Epidermal growth factor receptor Medicine Chemistry Oncology

UPDATE